Ridge Biotechnologies Emerges from Stealth with $25 Million in Seed Financing for AI-Enabled Precision Enzyme and Targeted Drug Design
Rollout of NativeLink and ProTrigger products for next-generation antibody conjugates, plus an ADC therapeutic discovery collaboration with a leading biotech, highlight early momentum PALO ALTO, Calif.–(BUSINESS WIRE)–Ridge Biotechnologies (Ridge Bio), a company pioneering enzyme and…